×

Kraig Biocraft Laboratories Announces Highly Favorable Testing Results for Its Big Red Spider Silk Fiber

Kraig Bancraft Logo

LANSING, Mich., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, today announced that the Company's initial testing of its recombinant spider silk, Big Red, indicate that the Company's new recombinant fiber is stronger than Monster Silk®. The testing indicates that Big Red's strength, as measured by the ultimate load it can withstand before breaking, is approaching that of natural spider silk.

"These initial testing results appear to confirm the effectiveness of our design approach with Big Red," said Company founder and CEO, Kim K. Thompson. "Big Red was designed to be even stronger than our breakthrough product, Monster Silk®," continued Thompson. "If the follow on testing confirms these results, Big Red will be a significant breakthrough for our Company and for material science."

"So far, Big Red has met or exceeded our expectations and design parameters. Our plan is for Big Red to follow Monster Silk® in our commercialization ramp up."

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc